Life Sciences Archive » December, 2021

Life Sciences - December, 2021

243 articles

• NY Jury Holds Teva Liable After Opioid Trial
• The Most-Read Legal Industry Guest Articles Of 2021
• Holmes Jury Asks To Rehear Ex-CEO's 2013 Investor Call
• Endo Gives Texas $63M In Latest Opioid Deal
• High Court To Review Federal Vaccine Mandates Next Month
• 5th Circ. Won't Revive Walmart's Opioid Suit Against Feds
• Opioid Judge's 'Many Errors' Ruined Trial, Pharmacies Charge
• Allergan Unit Says Linda Evangelista's $50M Suit Time-Barred
• Vaxart Can't Ditch Claims Co. Lied To Investors About Vaccine
• Judge Told CardioNet Owes $2.9M In Fees For 'Misconduct'
• Justices Told To Undo 'Impossible' Patent Enablement Rules
• CBD Co. Seeks Quick Win Over Ex-CEO In $5M Tax Bill Row
• Moderna Faces Complaint To SEC Over Vax Patent Row
• Pfizer Gets FDA Emergency Use Authorization For COVID Pills
• Judge Overrules 'State Secrets' Concerns In Valsartan MDL
• What DOJ's Cyberfraud Initiative Means For Health Cos.
• A Law Firm Leader's Guide To Seeking Effective Feedback
• Reed Smith-Advised Health Care SPAC Makes $75M Offering
• Top 5 Government Contracts Of 2021
• Novartis Inks Up To $1.5B Deal For Gyroscope Therapeutics
• UK Litigation Roundup: Here's What You Missed In London
• Janssen Denied Early Defeat Of HIV Medication FCA Suit
• DOJ Opioid Trial Team Tainted By Kirkland Ties, Ex-CEO Says
• Maine Asks 1st Circ. To Uphold Medical Pot Residency Rule
• 27 States, Groups Appeal Vax-Or-Test Rule To Justices
• Ill. Judge Refuses To Block Chicago, State Vax Mandates
• Holmes Judge Nixes Jury Request To Take Instructions Home
• Fla. Man Fights Pfizer's Escape Bid For Chantix Suit
• Purdue Asks To Keep Lawsuits Frozen Pending Ch. 11 Appeal
• Biden's Omicron Plan Details More At-Home Tests, Vax Sites
• Mylan Says Unharmed EpiPen Loyalists Undercut Class Cert.
• How Medical Device Cos. Can Limit Enforcement, Legal Risks
• Boston Scientific's Alice Challenge Flops In Del.
• Recalled P&G Deodorants Contained Carcinogens, Suit Claims
• Washington Nationals Tap Lorenger & Carnell For Vax Suit
• Weil, Fenwick Steer Sanofi's Up To $1.2B Deal For Amunix
• NJ Firm Wants To Toss Suit Over Benicar MDL Atty Fees
• Smith & Nephew Tries To Sink Pre-2009 Hip Implant Claims
• Major Merger Review Moments From 2021
• 11th Circ. Backs Hollister's $9M Win In Incontinence IP Row
• AbbVie Urges ITC To Block Humira Rival Over Trade Secrets
• Del. Judge Upholds Claims In Opioid Drug IP But Axes Others
• University Of Chicago Prof. Charged With Insider Trading
• Insurers Tell 11th Circ. To Nix Medical Co.'s Coverage Suit
• NJ Judge Won't Toss FCA Suit Over J&J Unit's Cancer Drug
• Embracing ESG: Whirlpool CLO Talks Structural Improvement
• 4 Big Issues That Shaped The PTAB In 2021
• Fed. Circ. Written Description Scrutiny Has Lessons For Attys
• Moderna Backs Off COVID Vaccine Patent In Dispute With NIH
• Holmes' Fate In Jury's Hands As Criminal Fraud Trial Wraps
• ITC Bans Chinese Massage Gun Imports Over Infringement
• Mallinckrodt Balks At Bid To Withdraw Acthar Antitrust Claims
• Apotex Asks Justices To Make Fed. Circ. Use Less 'Rigid' Test
• Seismic Purdue Ruling May Finally Get High Court's Attention
• LA Fitness Blames Virus For Closures In Revised Suit
• Cannabis Bill Roundup: GOP Reps. Chide Biden's Pot Inaction
• CBD Store Franchisee Launches New Suit Against Company
• Amtrak Vaccine Mandate Suit's Fate Uncertain After Ga. Ruling
• Fla. High Court Is Wrong To Ban CLE Diversity Requirements
• The 6 Most Important Bid Protest Decisions Of 2021
• Health Hires: Balt, McDermott Will & Emery
• Elite Horse Trainer Navarro Gets 5 Years In Doping Scandal
• Worker Can't Be Fired For Rebutting Review, Mass. Court Says
• Taxation With Representation: Skadden, Wachtell, Simpson
• 7th Circ. Revives 2 Cook Medical Vein Filter Suits
• IPO Stampede Powered Record Capital Markets Activity In '21
• BGI Units Lose Appeal Over Illumina DNA Sequencing IP
• UK Litigation Roundup: Here's What You Missed In London
• Biden Asks Supreme Court To Revive Health Worker Vax Rule
• Feds Portray Holmes As Mature Liar As Fraud Trial Nears End
• FDA To Allow Abortion Pills By Mail, Amid High Court Clash
• FDA Tosses Par Pharma's Anti-Generic Bid, Vows FTC Referral
• IP Forecast: Feds To Spar With Gilead Over CEO's Testimony
• Purdue Pharma's Ch. 11 Plan Is Unraveled On Appeal
• CDC Panel Recommends Pfizer, Moderna Over J&J Vax
• Texas Court Temporarily Stops Health Care Vaccine Mandate
• Lawyers Must Prepare For Contract Tech Co. Consolidation
• Bimbo Bakeries Sued In Wash. Over Toxic Metal Discharge
• Cravath Hires Assistant Director From FTC Merger Division
• Coppertone Buyers Get Final OK For $2.25M False Ad Deal
• High Court Speeds Up Texas Abortion Fight In 5th Circ.
• US Trustee Seeks Ch. 11 Examiner For J&J Talc Liability Unit
• Chancery Denies Alexion's Call To Revisit Fee Shift Ruling
• Disputing Plaintiff Expert Testimony In Product Liability Cases
• Defunct Opioid Distributor's Compliance Manager Takes Plea
• Holmes' 'Risky' Decision To Testify Could Save Her, Attys Say
• Mylan Can't Decertify EpiPen Antitrust Action Ahead Of Trial
• US Hemp Roundtable Pushes Back Against Ore. CBD Rules
• Cannabis Advocacy Org Urges Fed Action On CBD Regulation
• 5th Circ. Dials Back Block Of Health Care Vaccine Mandate
• Centene Hits Gilead With HIV Generic Antitrust Suit
• The Biggest Trademark Rulings Of 2021
• FDA Sends Medtronic Warning Over Diabetes Facility Issues
• Patent Groups Spar With Big Tech Over $2.7B Cisco Loss
• Jones Day Can Rep J&J Talc Unit In Ch. 11 For Now
• AbbVie's $550M Medical Device Deal Moving Ahead
• BigLaw's Big Guns Of Revenue Keep Growing
• Skadden, Wachtell Lead $6.5B Chipmaking Materials Co. Deal
• Opioid Makers Cement Calif. Win As Judge Spurns Objections
• Fed. Circ. Backs Ax Of Sunbio's Supplement TM
• Puma Biotech Investors Ink $54M Deal Over Drug Statements
• 4 Highlights From FDA Nominee Hearing
• Fla. Judge Trims Woman's Claims In Belviq Cancer Lawsuit
• CBD Co. Sued By Ex-CEO Over Surprise $5M Tax Bill
• Ex-Vyera CEO Criticizes Shkreli At Drug-Pricing Bench Trial
• What New FDA Policy Means For COVID Tests And Beyond
• Product Liability Risks Cannabis Companies Must Consider
• The Pandemic Patent Lawsuit Boom Continues
• How Firms Can Adapt Amid COVID's Shifting Legal Needs
• Ex-Pharma Worker's 'Dark Web' Suit Can Stand, 3rd Circ. Told
• Pharma Co. Seeks To Deny Novartis' 'Speculative' DQ Bid
• 3-Part Ch. 11 Stalking Horse Sale OK'd For Teligent
• Monsanto Successors Agree To $17.9M Superfund Cleanup
• Prestige Draws Young Attys, But Keeping Them Takes Work
• 4 Firms Assemble $11.6B Deal For Swiss Pharma Co.
• Split 5th Circ. Won't Block United Vax Mandate Amid Appeal
• NY Opioid Deliberations Delayed After Rancorous Closing Day
• Vanessa Hudgens Says Beauty Brand Faked Her Endorsement
• Mallinckrodt Says $1.75B Ch. 11 Opioid Deal Is Reasonable
• The Biggest Patent Rulings Of 2021
• Justices Won't Review FTC's Impax Ruling
• Contractor Says Resold Workout Machines Are Fed's Problem
• Embracing ESG: Synchrony Counsel Talk Role Of Legal Teams
• High Court Won't Block NY Health Care Worker Vax Mandate
• PTAB Discretionary Denials Are Unpredictable And Illegal
• Pa. DAs Say AG's $26B Opioid Deal Steps On Their Suits
• High Court Wants Feds' Input On $25M Roundup Verdict
• Justices Won't Hear J&J Challenge To Miss. AG's Talc Trial
• Prestige Leaders: A Look At Our New Law Firm Ranking
• The 2021 Law360 Pulse Prestige Leaders
• Prestige Leaders: Sizing Up Firms By Revenue
• 3 Firms Draw Up Pfizer's $6.7B Arena Pharmaceuticals Buy
• Holmes Jury Instructions Fight Touches On Celebrity, Balwani
• Court Asked To Create Fund In Atrium Defective Mesh MDL
• One Of 3M's N95 TM Suits Just Got More Complicated
• Cannabis Bill Roundup: The Prefiling Season Kicks Off
• The Top Product Liability Cases Of 2021
• Shkreli, Vyera To Settle Out Of BCBS Antitrust Class Action
• Mallinckrodt Calls Opioid, Acthar Deals Vital To Ch. 11 Plan
• House Report Finds 'Unfair' Drug Pricing Practices
• USPTO May Ditch Paper Patents, Trademark Certificates
• Rite Aid Broke Law By Changing Benefits, NLRB Judge Finds
• J&J Talc Spinoff's Ch. 11 Masquerading As Legit, Court Told
• Taxation With Representation: Ashurst, Freshfields, Gibson
• Short Sale Verdict Shows Need For Better Portfolio Disclosure
• Justices Let Texas Keep Its Abortion Law, But Clinics Can Sue
• Monsanto Snags Another Jury Victory In Calif. Roundup Trial
• US Trustee Wants Jones Day Booted From J&J Talc Ch. 11
• IP Forecast: Amazon To Fight Damages Theory In Patent Row
• No Teva Execs Testified In NY Opioid Trial, Jury Told
• Federal Judge Puts Calif. Pay-For-Delay Ban On Hold
• No Reconsideration Of Dismissal In DePuy Hip Implant Suit
• Deals Rumor Mill: Porsche, DuPont, Uber
• Hatch-Waxman Act Suits Set For 9-Year Low In 2021
• WilmerHale Steers Jeb Bush-Led SPAC's $200M IPO
• Bradley Arant Adds Ex-Gibson Dunn Atty To Litigation Team
• 3rd Fla. Federal Judge Recuses Himself In Battle Over Fees
• IPR's Effect On District Court Cases: Overlooked Concerns
• For Junior Lawyers, Authenticity And A Solid Pitch Are Key
• J&J Hip Implant FCA Case Tossed Over Secret Info Use
• Feds Say Chicago Doc Used Veterinary Catheters On Humans
• Hemp Equipment Seller Should Face RICO Claim, Court Told
• Fed. Circ. Gives Mylan 2nd Chance To Ax AstraZeneca IP
• Theranos Closings Near As Elizabeth Holmes Rests Defense
• Talc Claimants Say J&J Abusing Ch. 11 With Trust Motion
• Chinese Lung Cancer Biotech Lands $200M In Funding
• Opioid Sales Parody Videos Didn't Sway Docs, Jury Told
• US Shouldn't Abandon Phase 1 Agreement With China
• Ex-Insys Staffer Skirts Prison For Fentanyl Bribe Scheme
• Jones Day Hires Mass Tort Partner In Ohio
• A Compliance Primer For Attorneys Outsourcing Legal Work
• BGI Units Appeal DNA Sequencing Infringement Ruling
• Allergan Strikes $200M Deal To Exit NY Opioid Trial
• Brown Rudnick Adds FDA Expert To Life Sciences Group
• 3 Firms Lead £1.2B PE Buyout Of British Pharma Co. Clinigen
• Holmes Defends Theranos' 'Aggressive' IP Protection At Trial
• Former Shkreli Co. Inks Deal Worth Up To $40M With FTC, AGs
• Mallinckrodt Exec Says Ch. 11 Plan A Fair Deal For Creditors
• Opioid Jury Finally Sees Teva's Movie-Parody Sales Videos
• Fed. Circ. Won't Revive Teva Challenge To Drug Patent
• Full Fed. Circ. Told Teva Overreacting In Skinny Label IP Case
• What Vaccine Mandate Injunctions Mean For Health Employers
• Ex-Clinic Director Seeks Early Win In FCA Kickbacks Suit
• J&J Talc Sub Names Pick For Ch. 11 Future Claims Rep
• Why Boards Shouldn't Reject Investors' Misconduct Claims
• Supply Chain Indemnification Tips For Medical Device Cos.
• Robbins Geller, Friedlander & Gorris To Lead Biotech Sale Suit
• Solution To Patent Eligibility Quagmire Lies In Constitution
• 4 Firms Shape Biosimilar Biz Alvotech's $2.3B SPAC Deal
• When And How To Depose Fact Witnesses Remotely In 2022
• Fla. Pharmacy Owner Convicted Of Mail Fraud
• Jury Gives Composite Resources Win In Tourniquet IP Row
• Warby Parker Wants 1-800 Contacts' 'Thin' Search Suit Nixed
• 11th Circ. Denies Fla. Bid To Halt Fed Health Workers Vax Rule
• SEC Hits Dialysis Co., Execs With Accounting Fraud Claim
• Judge Puts End To E-Cig Patent Suit Against Philip Morris
• Justices Told Fed. Circ. Wrongly Kills Patents PTAB Upholds
• Feds Say NJ Pharma CEO Pilfered Nearly $4M From His Co.
• Sackler Family Denies Pre-Ch. 11 Looting Of Purdue Pharma
• Elite Horse Trainer Navarro Asks For Leniency In Doping Case
• Blood Clot Device Maker Must Face Suit In Ill., Court Rules
• JP Morgan Ruling May Have Broad Insurance Implications
• Embracing ESG: PayPal CLO Talks Gauging Impact And Intent
• Freshfields, Latham Lead Saint-Gobain's $2.3B Deal For GCP
• Mallinckrodt Escapes $320M Acthar Antitrust Claim In Ch. 11
• Hedge Fund Priest Seeks Total Victory Over SEC Stock Suit
• Feds Seek To Stay Order Blocking Contractor Vax Mandate
• Walgreens Medicaid FCA Suit Tossed Over Federal Law Clash
• Cannabis Bill Roundup: House Members Pitch New CBD Bill
• Holmes Attys Rip 'Confusing' Jury Instructions On Fraud
• UK Watchdog Clears Thermo Fisher's $21B PPD Deal
• States Say AMG Case Can't Save Drugmakers In Price-Fix Suit
• Maryland Atty Charged With $8.5M Escrow Fraud In NY Court
• Zoll Medical Escapes Liability For Alleged Defibrillator Defect
• How Growing Cyber Scrutiny Affects Corporate Compliance
• Class Attys Get $540K In Dollar General False Ad Suit
• New Patent Ownership Bill Should Better Balance Rights
• Medicinal Standards Org Urges More Testing Of Delta-8 THC
• NY Court Revives Faulty Heart Valve Replacement Suit
• Med Device Maker Valued At $2.25B In Minority Investment
• Advent, GIC Drop $8B Bid For Swedish Drugmaker Sobi
• UK Litigation Roundup: Here's What You Missed In London
• IP Forecast: 9th Circ. To Eye Class Cert. In Rock Music Fight
• Rockefeller U. Wins CRISPR Interference Battle At PTAB
• Blackstone REIT Lands $690M In Financing From 2 Banks
• Attys Seek $113M In Fees From Glumetza Buyers' $454M Deal
• FTC Pushing Caris Life Sciences For Merger Challenge Docs
• Former Pharma CFO, Ex-Girlfriend Accused Of Insider Trading
• 6th Circ. Affirms No Intervention In Flint Water Deal
• Gov't Contracts Of The Month: Meds, Jets, Military Moves
• Military Members Can't Fight DOD Vax Mandate Anonymously
• WTO Chief Wants Deal On Vaccines, Fisheries Early Next Year
• Lawmakers Urge VA To Let Vets Access Medical Pot
• Deals Rumor Mill: Lundin Energy, Vifor Pharma, Lone Star
• Fed. Circ. Won't Let Moderna Undo Rulings Tied To COVID Vax
• Buchanan Ingersoll Objects To Fee Split In Discovery Dispute
• Talc Claimants Seek To Toss J&J Unit's 'Manufactured' Ch. 11
• Judge Unsure If He Can Rule On Future Mallinckrodt Deal
• Imerys, Cyprus Get Go-Ahead For Mediation In Ch. 11 Cases
• Ohio Opioid Verdict Brings Focus To Role Of Pharmacists
• Climate Change Lawsuits Are Not 'The New Tobacco'
• Chancery Tosses Most Counts Aimed At Vaccine Firm Insiders
• NorthShore Workers Denied Injunction In Vax Mandate Suit